KRINGLE PHARMA: Addition of clinical trial implementation facilities (Sanno Medical Center) to phase III clinical trials of HGF (hepatocyte growth factor) for vocal cord scars

JPX · May 16 14:10

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.